Treatment of Night Terrors in Adults
The evidence base for treating night terrors (sleep terrors) in adults is extremely limited, with no high-quality guidelines specifically addressing this condition—the available AASM guidelines focus exclusively on nightmare disorder, which is a distinct REM-sleep parasomnia with different pathophysiology and treatment approaches than night terrors, a non-REM disorder of arousal.
Critical Distinction: Night Terrors vs. Nightmares
Night terrors arise from stage 3 non-REM (slow-wave) sleep, typically in the first third of the night, and involve abrupt partial arousal with intense fear, screaming, autonomic hyperactivity (tachycardia, diaphoresis, dilated pupils), confusion, and complete amnesia for the event 1, 2.
Nightmares occur during REM sleep, involve vivid dream recall, full alertness upon awakening, and minimal autonomic symptoms—these are the focus of all provided AASM guidelines 3.
The treatments recommended for nightmare disorder (image rehearsal therapy, prazosin, cognitive behavioral therapy) are NOT applicable to night terrors because they target different sleep stages and mechanisms 3.
First-Line Management: Behavioral Interventions
Address precipitating factors and optimize sleep hygiene as the primary intervention, since sleep deprivation and factors increasing sleep fragmentation are the most common triggers for night terrors in adults.
Ensure adequate total sleep time (7-9 hours) and regular sleep-wake schedules, as homeostatic sleep pressure from sleep deprivation primes arousal disorders 1, 2.
Identify and eliminate sleep fragmenting factors: obstructive sleep apnea, periodic limb movements, alcohol use, caffeine late in the day, stress, and medications that disrupt sleep architecture 1, 2.
Implement safety measures: remove dangerous objects from the bedroom, secure windows, consider door alarms, and place mattress on the floor if injury risk is high 1, 2.
Scheduled awakenings may be effective: wake the patient 15-30 minutes before the typical time of night terror occurrence (usually 60-90 minutes after sleep onset) for several consecutive nights 2.
Pharmacologic Options (Limited Evidence)
When behavioral measures fail and episodes cause significant injury risk or functional impairment, consider short-term pharmacotherapy, recognizing that evidence consists only of case reports and small case series.
Clonazepam (Most Commonly Used)
Clonazepam 0.5-2 mg at bedtime is the most frequently cited pharmacologic intervention for adult night terrors, though evidence is limited to clinical experience rather than controlled trials 1, 2.
Mechanism: Suppresses stage 3-4 non-REM sleep and reduces arousals from deep sleep 1.
Important caveat: The AASM explicitly states clonazepam is not recommended for nightmare disorder 3, but this recommendation does not apply to night terrors, which have different pathophysiology.
Use short-term only (weeks to months) due to tolerance, dependence risk, and cognitive side effects 1, 2.
Tricyclic Antidepressants (Historical Data)
Imipramine 25-75 mg at bedtime showed benefit in small case series from the 1970s-1980s, with complete resolution or marked reduction in night terrors in adults with post-traumatic presentations 4, 5.
Mechanism: Suppresses stage 4 sleep and may have arousal-preventing effects 5.
Diazepam was ineffective in the same patients who responded to imipramine, despite theoretical benefit from stage 4 suppression 4.
Selective Serotonin Reuptake Inhibitors
SSRIs are mentioned as potential treatment options in review literature, though no specific dosing or efficacy data are provided 6.
Rationale: May address underlying anxiety or stress that precipitates episodes 6.
Psychotherapy for Adults
Consider psychotherapy when night terrors persist despite behavioral and pharmacologic interventions, particularly if psychological stressors or trauma are identified.
Individual psychotherapy eliminated or drastically reduced night terrors in 2 of 3 adult patients in a small case series, suggesting psychopathology may play a primary role in adult-onset cases 7.
This contrasts with childhood night terrors, which are typically developmental and self-limited 2.
Stress management and counseling addressing life circumstances, relationships, and personality factors may reduce episode frequency 6.
Clinical Algorithm for Adult Night Terrors
Confirm diagnosis: Episodes arise from stage 3 non-REM sleep in first third of night, with amnesia and autonomic hyperactivity, distinguishing from nightmares (REM sleep, dream recall) 1, 2.
Screen for precipitants: Evaluate for sleep deprivation, obstructive sleep apnea (consider polysomnography if snoring/witnessed apneas), alcohol use, medications, and psychological stressors 1, 2.
Implement behavioral measures: Optimize sleep hygiene, ensure 7-9 hours sleep opportunity, eliminate sleep fragmenting factors, and establish safety precautions 1, 2.
Trial scheduled awakenings if episodes occur predictably at same time each night 2.
If episodes persist with injury risk or severe functional impairment after 4-6 weeks: Initiate clonazepam 0.5 mg at bedtime, titrate to 1-2 mg as needed 1, 2.
If clonazepam ineffective or contraindicated: Consider imipramine 25-50 mg at bedtime, titrate to 75 mg based on historical case data 4, 5.
Refer for psychotherapy if pharmacologic approaches fail or if significant psychosocial stressors are identified 7.
Common Pitfalls
Do not apply nightmare disorder treatments (image rehearsal therapy, prazosin, trauma-focused CBT) to night terrors—these target REM sleep phenomena and will not address non-REM arousal disorders 3, 1.
Do not attempt to wake or restrain the patient during an episode—this may prolong the event or provoke aggressive behavior; instead, gently guide them back to bed and ensure safety 1, 2.
Avoid long-term benzodiazepine use due to tolerance, dependence, cognitive impairment, and fall risk, particularly in older adults 1.
Rule out nocturnal seizures if episodes are stereotyped, occur multiple times per night, or include unusual motor phenomena—consider EEG or video-EEG monitoring 1.